NDA/BLA filedoutcome: unknownconf 0.95

kresladi — NDA/BLA filed

$RCKT · ROCKET PHARMACEUTICALS, INC. · Treatment of pediatric patients with severe leukocyte adhesion deficiency-I (LAD-I) due to biallelic variants in ITGB2 without an available human leukocyte antigen-matched sibling donor for allogeneic hematopoietic stem cell transplant

Event date

October 14, 2025

235 days ago

Sponsor runway

10 mo

$144.4M liquid

Evidence

“On October 14, 2025, Rocket Pharmaceuticals, Inc. (the \”

Source: 8-K filed 2025-10-14View on EDGAR ↗0001140361-25-038030

Comparable historical nda/bla fileds· last 5 years · same indication

Ticker	Drug	Date	Outcome
$RCKT	kresladi	2023-10-02	unknown

Recent insider activity· ±90 days

9 insiders · 2 buys · 17 sells

Buy

2026-01-02

Bjork Elisabeth

Director

10,000 @ $3.44$34K

Sell

2025-11-18

Shah Gaurav

CEO

6,276 @ $2.98$19K

Sell

2025-11-18

Wilson Martin

General Counsel

1,646 @ $2.98$5K

Sell

2025-11-18

Schwartz Jonathan David

See Remarks

2,545 @ $2.98$8K

Sell

2025-11-18

Militello John

See Remarks

1,086 @ $2.98$3K

Grant

2025-11-03

Wilson Martin

General Counsel

100,000 @ ——

Sell

2025-10-14

Militello John

See Remarks

558 @ $3.98$2K

Sell

2025-10-14

Militello John

See Remarks

3,005 @ $3.97$12K

Sell

2025-10-14

Militello John

See Remarks

19,841 @ $3.96$79K

Sell

2025-10-14

Militello John

See Remarks

5,514 @ $3.96$22K

Grant

2025-10-06

Rizvi Syed Ali-aamir

Chief Medical Officer

283,018 @ ——

Grant

2025-10-06

Rizvi Syed Ali-aamir

Chief Medical Officer

62,893 @ ——

Grant

2025-10-06

Rizvi Syed Ali-aamir

Chief Medical Officer

383,854 @ ——

Grant

2025-09-24

Fong Peter

Director

23,333 @ ——

Grant

2025-09-24

Fong Peter

Director

30,000 @ ——

Opt-Exer

2025-09-19

RTW INVESTMENTS, LP

Director

1,000,000 @ $40.03$40.03M

Other

2025-09-19

RTW INVESTMENTS, LP

Director

1,000,000 @ $3.10$3.10M

Opt-Exer

2025-09-19

RTW INVESTMENTS, LP

Director

41,000 @ $19.09$783K

Other

2025-09-19

RTW INVESTMENTS, LP

Director

41,000 @ $3.10$127K

Opt-Exer

2025-09-19

RTW INVESTMENTS, LP

Director

59,000 @ $17.81$1.05M

Other

2025-09-19

RTW INVESTMENTS, LP

Director

59,000 @ $3.10$183K

Opt-Exer

2025-09-19

RTW INVESTMENTS, LP

Director

1 @ ——

Grant

2025-09-08

Schwartz Jonathan David

See Remarks

80,000 @ ——

Grant

2025-09-08

Militello John

See Remarks

40,000 @ ——

Grant

2025-09-08

Wilson Martin

General Counsel

150,000 @ ——

Buy

2025-08-27

Bjork Elisabeth

Director

10,000 @ $3.41$34K

Sell

2025-08-19

Militello John

See Remarks

361 @ $3.00$1K

Sell

2025-08-19

Schwartz Jonathan David

See Remarks

805 @ $3.00$2K

Sell

2025-08-19

Wilson Martin

General Counsel

588 @ $3.00$2K

Tax

2025-08-18

Shah Gaurav

CEO

2,234 @ $3.05$7K

Sell

2025-08-18

Militello John

See Remarks

699 @ $3.06$2K

Sell

2025-08-18

Schwartz Jonathan David

See Remarks

1,680 @ $3.06$5K

Sell

2025-08-18

Wilson Martin

General Counsel

1,004 @ $3.06$3K

Sell

2025-08-14

Militello John

See Remarks

7,043 @ $3.02$21K

Sell

2025-08-14

Wilson Martin

General Counsel

12,109 @ $3.02$37K

Sell

2025-08-14

Schwartz Jonathan David

See Remarks

11,161 @ $3.02$34K

Grant

2025-08-04

Stevens Christopher James

Chief Operating Officer

554,071 @ ——

Grant

2025-08-04

Stevens Christopher James

Chief Operating Officer

407,166 @ ——

Date	Insider	Action	Shares	Price	Value
2026-01-02	Bjork ElisabethDirector	Buy	10,000	$3.44	$34K
2025-11-18	Shah GauravCEO	Sell	6,276	$2.98	$19K
2025-11-18	Wilson MartinGeneral Counsel	Sell	1,646	$2.98	$5K
2025-11-18	Schwartz Jonathan DavidSee Remarks	Sell	2,545	$2.98	$8K
2025-11-18	Militello JohnSee Remarks	Sell	1,086	$2.98	$3K
2025-11-03	Wilson MartinGeneral Counsel	Grant	100,000	—	—
2025-10-14	Militello JohnSee Remarks	Sell	558	$3.98	$2K
2025-10-14	Militello JohnSee Remarks	Sell	3,005	$3.97	$12K
2025-10-14	Militello JohnSee Remarks	Sell	19,841	$3.96	$79K
2025-10-14	Militello JohnSee Remarks	Sell	5,514	$3.96	$22K
2025-10-06	Rizvi Syed Ali-aamirChief Medical Officer	Grant	283,018	—	—
2025-10-06	Rizvi Syed Ali-aamirChief Medical Officer	Grant	62,893	—	—
2025-10-06	Rizvi Syed Ali-aamirChief Medical Officer	Grant	383,854	—	—
2025-09-24	Fong PeterDirector	Grant	23,333	—	—
2025-09-24	Fong PeterDirector	Grant	30,000	—	—
2025-09-19	RTW INVESTMENTS, LPDirector	Opt-Exer	1,000,000	$40.03	$40.03M
2025-09-19	RTW INVESTMENTS, LPDirector	Other	1,000,000	$3.10	$3.10M
2025-09-19	RTW INVESTMENTS, LPDirector	Opt-Exer	41,000	$19.09	$783K
2025-09-19	RTW INVESTMENTS, LPDirector	Other	41,000	$3.10	$127K
2025-09-19	RTW INVESTMENTS, LPDirector	Opt-Exer	59,000	$17.81	$1.05M
2025-09-19	RTW INVESTMENTS, LPDirector	Other	59,000	$3.10	$183K
2025-09-19	RTW INVESTMENTS, LPDirector	Opt-Exer	1	—	—
2025-09-08	Schwartz Jonathan DavidSee Remarks	Grant	80,000	—	—
2025-09-08	Militello JohnSee Remarks	Grant	40,000	—	—
2025-09-08	Wilson MartinGeneral Counsel	Grant	150,000	—	—
2025-08-27	Bjork ElisabethDirector	Buy	10,000	$3.41	$34K
2025-08-19	Militello JohnSee Remarks	Sell	361	$3.00	$1K
2025-08-19	Schwartz Jonathan DavidSee Remarks	Sell	805	$3.00	$2K
2025-08-19	Wilson MartinGeneral Counsel	Sell	588	$3.00	$2K
2025-08-18	Shah GauravCEO	Tax	2,234	$3.05	$7K
2025-08-18	Militello JohnSee Remarks	Sell	699	$3.06	$2K
2025-08-18	Schwartz Jonathan DavidSee Remarks	Sell	1,680	$3.06	$5K
2025-08-18	Wilson MartinGeneral Counsel	Sell	1,004	$3.06	$3K
2025-08-14	Militello JohnSee Remarks	Sell	7,043	$3.02	$21K
2025-08-14	Wilson MartinGeneral Counsel	Sell	12,109	$3.02	$37K
2025-08-14	Schwartz Jonathan DavidSee Remarks	Sell	11,161	$3.02	$34K
2025-08-04	Stevens Christopher JamesChief Operating Officer	Grant	554,071	—	—
2025-08-04	Stevens Christopher JamesChief Operating Officer	Grant	407,166	—	—

← All catalysts for $RCKT